Skip to content

Clinical trials

Phase 3 Shock, Hemorrhagic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Shock, Hemorrhagic Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20151
20161
20171
20182
20223
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Not yet recruiting1
Recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jason Sperry2
Arrowhead Regional Medical Center1
Australian and New Zealand Intensive Care Research Centre1
Cristina Martinez1
French Defence Health Service1
Innogene Kalbiotech Pte. Ltd1
Loma Linda University1
Northfield Laboratories1
Philip Spinella1
The University of Texas Health Science Center, Houston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Shock, Hemorrhagic15
Hemorrhage6
Wounds and Injuries6
Accidental Injuries2
Hemostatic Disorders2
Shock2
Brain Injuries, Traumatic1
Gastrointestinal Hemorrhage1
Hypocalcemia1
Inflammation1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.